Acceleron gains 33% in first day; Bind prices IPO
This article was originally published in Scrip
Executive Summary
Acceleron Pharma soared 33.3% above its $15 initial public offering price on the stock's first day of trading and Bind Therapeutics priced its IPO at $15 per share after the market closed on 19 September.